<H1> LATEST NEWSRead more...
</H1> |
<H1> press releasesRead more...
</H1> |
<H1> EventsRead more...
</H1> |
<H1> TOP ARTICLES </H1> |
<H1> 1 </H1> |
<H1> 2 </H1> |
<H1> 3 </H1> |
<H1> 4 </H1> |
<H1> 5 </H1> |
<H1> KNOWLEDGE BANK </H1> |
<H1> Advisory Board </H1> |
<H1> EDITORIAL SECTION </H1> |
<H2> RAPT Therapeutics Announces Initiation of Phase 2a Trial of RPT193 in Patients with Moderate-to-Severe Asthma </H2> |
<H2> Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million </H2> |
<H2> Neutra’s Strategic Move to Put the Organization in Position to Achieve Its Plans for Growth </H2> |
<H2> MImetaS and Astellas Enter into Strategic Partnership on Immuno-Oncology </H2> |
<H2> Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease </H2> |
<H2> Amicus Therapeutics Announces European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease </H2> |
<H2> Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics </H2> |
<H2> Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference </H2> |
<H2> Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards </H2> |
<H2> AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production </H2> |
<H2> Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases </H2> |
<H2> Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-617, a Novel Fusion Protein Harnessing IL-2 and IL-12 Cytokines </H2> |
<H2> Precision in Drug Discovery & Preclinical Summit </H2> |
<H2> American Biomanufacturing Summit </H2> |
<H2> European Clinical Trial Supply Forum </H2> |
<H2> CPHI Japan </H2> |
<H2> Global Pharma & Drug Delivery Summit </H2> |
<H2> Pharmaceutical Compliance Congress </H2> |
<H2> Pharmaceutical Microbiology East Coast </H2> |
<H2> Precision in Clinical Trials Summit </H2> |
<H2> Plant-derived Edible Nanoparticles in Delivering Cancer Drugs: Fact or Fad? </H2> |
<H2> Harnessing the Intracellular Machinery to Degrade Cellular Proteins </H2> |
<H2> Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease </H2> |
<H2> Role of QSAR in filling in the gaps of CoVID-19 Therapeutics </H2> |
<H2> Role of Artificial Intelligence in Pharmaceutical Industry </H2> |
<H2> Articles </H2> |
<H2> Spleen Cytokines Against Inflammatory Bowel Disease </H2> |
<H2> Plant-derived Edible Nanoparticles in Delivering Cancer Drugs: Fact or Fad? </H2> |
<H2> Harnessing the Intracellular Machinery to Degrade Cellular Proteins </H2> |
<H2> Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease </H2> |
<H2> Role of QSAR in filling in the gaps of CoVID-19 Therapeutics </H2> |
<H2> Role of Artificial Intelligence in Pharmaceutical Industry </H2> |
<H2> Research Insights </H2> |
<H2> Renal Drug Transporters And Their Significance In Drug–drug Interactions </H2> |
<H2> Techno Trends </H2> |
<H2> Novel Elecsys Growth Differentiation Factor-15 (GDF-15) Assay Discovered for Cancer Treatment </H2> |
<H2> STRATEGY </H2> |
<H2> THE ECOSYSTEM PARADIGM </H2> |
<H2>
RESEARCH DEVELOPMENT
</H2> |
<H2> INTEGRATIVE ASSOCIATIVE CLASSIFICATION FOR CANCER BIOMARKER DISCOVERY </H2> |
<H2>
CLINICAL TRIALS
</H2> |
<H2> Low Rates of Stroke and Major Bleeding with Rivaroxaban Confirmed by Global Study </H2> |
<H2>
MANUFACTURING
</H2> |
<H2> Sustainable Packaging </H2> |
<H2>
Information Technology
</H2> |
<H2> Creating Better Clean Label Soft Gels Without Gelatin Crosslinking </H2> |
<H2>
EXPERT Talk
</H2> |
<H3> Model-Informed Drug Development (MIDD) - EMA's Advancement </H3> |
<H3> HYBRID EXOSOMES: A Novel Platform for Cancer Therapy </H3> |
<H3> Effective Biomarkers in Uncovering Novel Target Molecules for a Drug </H3> |
<H3> C-MET Receptor Tyrosine Kinase: A Potential Biomarker for Cancer Therapeutics </H3> |
<H3> New Pharmacological Targets and Biomarkers for the Treatment of Tuberculosis (TB) </H3> |
<H3> BENEFITS AND CHALLENGES OF USING WEARABLES IN CLINICAL TRIALS </H3> |
<H3> Decentralising Clinical Trials for Better Drug Formulations </H3> |
<H3> Additive Manufacturing as a Problem-Solving Tool in Pharmaceutical Processing </H3> |
<H3> 3D Printing: What's in Store for Medicine in the Future </H3> |
<H3> Cold-Chain Considerations for Manufacturing today’s Advanced Biologics </H3> |
<H3> FUTURE OF CLINICAL TRIALS AND TECHNOLOGY INNOVATIONS </H3> |
<H3> THE PHARMACEUTICAL INDUSTRY AND DATA SCIENCE </H3> |
<H3> Role of Artificial Intelligence and Machine Learning in Nanosafety </H3> |
<H3> 30 </H3> |
<H3> 30 </H3> |
<H3> 29 </H3> |
<H3> 29 </H3> |
<H3> 28 </H3> |
<H3> 28 </H3> |
<H3> 29 </H3> |
<H3> 29 </H3> |
<H3> 28 </H3> |
<H3> 28 </H3> |
<H3> 27 </H3> |
<H3> 27 </H3> |
<H3> 03 - 04 </H3> |
<H3> 12 - 13 </H3> |
<H3> 18 - 19 </H3> |
<H3> 19 - 21 </H3> |
<H3> 24 - 26 </H3> |
<H3> 25 - 27 </H3> |
<H3> 27 - 28 </H3> |
<H3> 01 - 02 </H3> |
<H5> Get instant access to latest e-book </H5> |
<H5> Ryan Varghese </H5> |
<H5> </H5> |
<H5> Abha Deshpande </H5> |
<H5> </H5> |
<H5> Jainam Karsiya </H5> |
<H5> </H5> |
<H5> Dileep Kumar </H5> |
<H5> </H5> |
<H5> Marco Pirisinu </H5> |
<H5> </H5> |
<H5> Ruchi Chawla </H5> |
<H5> </H5> |
<H5> Varsha Rani </H5> |
<H5> </H5> |
<H5> Mohini Misra </H5> |
<H5> </H5> |
<H5> Krishan Kumar </H5> |
<H5> </H5> |
<H5> Smriti Sharma Bhatia </H5> |
<H5> </H5> |
<H5> Yousuf Khan </H5> |
<H5> </H5> |
<H5> Kunika Saini </H5> |
<H5> </H5> |
<H5> Priya Patel </H5> |
<H5> </H5> |
<H5> A Product of </H5> |
<H5> Quick Links </H5> |
<H5> Get in Touch </H5> |
Social
Social Data
Cost and overhead previously rendered this semi-public form of communication unfeasible.
But advances in social networking technology from 2004-2010 has made broader concepts of sharing possible.